UK NICE Recommends NHS Funding for Arrowhead’s Redemplo in Adults With FCS

The UK National Institute for Health and Care Excellence recommends NHS funding for Redemplo (plozasiran) for adults with genetically confirmed familial chylomicronemia syndrome.